logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

Jonathan A. Ledermann

university college london

89H-index
502Paper Count
5.0WCitation Count
Published Papers 139
Publication Date
logo
Best original research presented at the 27th European Congress on Gynaecological Oncology: best of ESGO 2026
errInternational Journal of Gynecological Cancer
IF4.7
err2026-07-11
err0
PREAI
errHoussein El Hajj; Alexander Shushkevich; Joanna Kacperczyk-Bartnik; Andrej Cokan; Ilker Kahramanoglu; Tibor Andrea Zwimpfer; Richard Tóth; Aleksandra Strojna; David Viveros-Carreño; Nicolò Bizzarri; Martina Aida Angeles; Khayal Gasimli; Ilker Selcuk; Giuseppe Caruso; Jonathan Ledermann; Viola Heinzelmann-Schwarz
errShare
errSave
Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial
errInternational Journal of Gynecological Cancer
IF4.7
err2026-03-02
err0
errOAAI
errJonathan A. Ledermann; Alain Lortholary; Richard T. Penson; Rebecca Asher; Val Gebski; Diane Provencher; Ilan Bruchim; Tomasz Huzarski; Maria Pilar Barretina-Ginesta; Stefania Pipitone; Linda Mileshkin; Nicoletta Colombo; Tjoung-Won Park-Simon; Koji Matsumoto; Ingrid Boere; Olga Mikheeva; Jae-Weon Kim; Gustavo Girotto; Ignace Vergote; Dave Carter
errShare
errSave
The PARP inhibitor/Immunotherapy Paradox in Advanced Ovarian Cancer: Positive Endpoints, Perplexing Interpretations
errAnnals of Oncology
IF65.4
err2025-12-11
err0
PREAI
errJonathan A. Ledermann; Robert L. Coleman
errShare
errSave
INTERLACE: not a new standard for cervical cancer chemoradiation – Authors' reply
errlancet
IF0
err2025-08-21
err0
PREAI
errMary McCormack; Gemma Eminowicz; Simran Vaja; Allan Hackshaw; Jonathan Ledermann
errShare
errSave
The ENYGO Multidisciplinary Tumor Board Mechanisms of drug resistance: PARP inhibitors, Antibody-drug-conjugates (ADCs), and Immunotherapy
errInternational Journal of Gynecological Cancer
IF4.7
err2025-08-19
err0
PREAI
errDiana Bello Roufai; Richard Toth; Upasana Palo; Giula Scaglione; Ana Tatiana Palacios; Zoltan Novak; Houssein El Hajj; Alexander Shushkevich; Jonathan Ledermann
errShare
errSave
ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma: update 2025
errlancet oncology
IF0
err2025-07-28
err0
PREAI
errNicole Concin; Xavier Matias-Guiu; David Cibula; Nicoletta Colombo; Carien L Creutzberg; Jonathan Ledermann; Mansoor Raza Mirza; Ignace Vergote; Nadeem R Abu-Rustum; Tjalling Bosse; Cyrus Chargari; Sophie Espenel; Anna Fagotti; Christina Fotopoulou; Sonia Gatius; Antonio González-Martin; Sigurd Lax; Bar Levy; Domenica Lorusso; Gabriella Macchia; Christian Marth; Philippe Morice; Ana Oaknin; Maria Rosaria Raspollini; Richard Schwameis; Jalid Sehouli; Alina Sturdza; Alexandra Taylor; Anneke Westermann; Pauline Wimberger; François Planchamp; Remi A Nout
errShare
errSave
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
errEuropean Journal of Cancer
IF7.1
err2025-06-17
err0
errOAAI
errJonathan A. Ledermann; Amit M. Oza; Domenica Lorusso; Carol Aghajanian; Ana Oaknin; Andrew Dean; Nicoletta Colombo; Johanne I. Weberpals; Andrew R. Clamp; Giovanni Scambia; Alexandra Leary; Robert W. Holloway; Margarita Amenedo Gancedo; Peter C. Fong; Jeffrey C. Goh; David M. O’Malley; Deborah K. Armstrong; Susana Banerjee; Jesús García-Donas; Elizabeth M. Swisher; Robert L. Coleman
errShare
errSave
Controversies and clinical unknowns in the use of PARP inhibitors in ovarian cancer
errTherapeutic Advances in Medical Oncology
IF4.2
err2025-06-14
err0
errOAAI
errUma A. Mukherjee; Rowan E. Miller; Jonathan A. Ledermann
errShare
errSave
Maintenance olaparib monotherapy in patients with platinum-sensitive relapsed ovarian cancer without a germline BRCA1 and/or BRCA2 mutation: Final overall survival results from the OPINION trial
errgynecologic oncology
IF4.1
err2025-06-01
err0
errOAAI
errPoveda, Andres; Lheureux, Stephanie; Colombo, Nicoletta; Cibula, David; Elstrand, Mari; Weberpals, Johanne; Bjurberg, Maria; Oaknin, Ana; Sikorska, Magdalena; Gonzalez-Martin, Antonio; Madry, Radoslaw; Perez, Maria Jesus Rubio; Ledermann, Jonathan; Romero, Ignacio; Ozgoren, Ozan; Barnicle, Alan; Marshall, Helen; Bashir, Zahid; Kof, Erik
errShare
errSave
Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial
errEUROPEAN JOURNAL OF CANCER
IF7.1
err2025-05-01
err0
PREAI
errEminowicz, G.; Vaja, S.; Gallardo, D.; Kent, C.; Panades, M.; Mathew, T.; Anand, A.; Forrest, J.; Adusumalli, M.; Chan, A.; Hacker, A. M.; Hackshaw, A.; Ledermann, J. A.; McCormack, M.
errShare
errSave
A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population☆
errInternational Journal of Gynecological Cancer
IF4.7
err2025-04-19
err0
PREAI
errEve Merry; Ronas Taner Kesmez; Tamara Yu; Michael Flynn; Jonathan Ledermann; Michelle Lockley; Nicola Macdonald; Mary McCormack; Shibani Nicum; Shanthini Crusz; Rowan Miller
errShare
errSave
ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety
errgynecologic oncology
IF4.1
err2025-04-01
err0
PREAI
errMatulonis, Ursula A.; Herrstedt, Jorn; Oza, Amit; Mahner, Sven; Redondo, Andres; Berton, Dominique; Berek, Jonathan S.; Haslund, Charlotte A.; Marme, Frederik; Gonzalez-Martin, Antonio; Becourt, Stephanie; Tinker, Anna, V; Ledermann, Jonathan A.; Benigno, Benedict; Lindahl, Gabriel; Colombo, Nicoletta; Malinowska, Izabela A.; Liu, Wenlei; Bains, Manjinder; Monk, Bradley J.; Mirza, Mansoor R.
errShare
errSave
Controversies in the management of rare gynecologic cancers
errINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
err2025-03-01
err0
PREAI
errGershenson, David M.; Ledermann, Jonathan; Ray-Coquard, Isabelle
errShare
errSave
Incorporating immune checkpoint inhibitors in epithelial ovarian cancer
errgynecologic oncology
IF4.1
err2025-02-01
err7
PREAI
errBogani, Giorgio; Moore, Kathleen N.; Ray-Coquard, Isabelle; Lorusso, Domenica; Matulonis, Ursula A.; Ledermann, Jonathan A.; Gonzalez-Martin, Antonio; Kurtz, Jean-Emmanuel; Pujade-Lauraine, Eric; Scambia, Giovanni; Caruso, Giuseppe; Raspagliesi, Francesco; Colombo, Nicoletta; Monk, Bradley J.
errShare
errSave
The Incidence Of Breast Cancer In Ovarian Cancer Patients With BRCA Mutations: A Multicentre Retrospective Cohort Study.
errINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
err2025-02-01
err0
PREAI
errYongue, Gabriella; Counsell, Nicholas; Morgan, Robert D.; Tookman, Laura; Devlin, Michael-John; Miller, Rowan; Modawi, Mumin; Leytes, Sophia; Hunt, Ashton; Clamp, Andrew R.; Evans, Gareth R.; Jayson, Gordon C.; Elyashiv, Osnat; Levy, Tally; Abu Remilah, Areen; Ledermann, Jonathan A.; Nicum., Shibani
errShare
errSave
Patterns of genomic instability in > 2000 patients with ovarian cancer across six clinical trials evaluating olaparib
errGENOME MEDICINE
IF11.2
err2024-12-18
err0
errOAAI
errBarnicle, Alan; Ray-Coquard, Isabelle; Rouleau, Etienne; Cadoo, Karen; Simpkins, Fiona; Aghajanian, Carol; Leary, Alexandra; Poveda, Andres; Lheureux, Stephanie; Pujade-Lauraine, Eric; You, Benoit; Ledermann, Jonathan; Matulonis, Ursula; Gourley, Charlie; Timms, Kirsten M.; Lai, Zhongwu; Hodgson, Darren R.; Elks, Cathy E.; Dearden, Simon; Egile, Coumaran; Lao-Sirieix, Pierre; Harrington, Elizabeth A.; Brown, Jessica S.
errShare
errSave
Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3trial
errLANCET
IF88.5
err2024-10-01
err4
errOAAI
errMcCormack, Mary; Eminowicz, Gemma; Gallardo, Dolores; Diez, Patricia; Farrelly, Laura; Kent, Christopher; Hudson, Emma; Panades, Miguel; Mathew, Tony; Anand, Anjana; Persic, Mojca; Forrest, Jennifer; Bhana, Rajanee; Reed, Nicholas; Drake, Anne; Adusumalli, Madhavi; Mukhopadhyay, Asima; King, Margaret; Whitmarsh, Karen; McGrane, John; Colombo, Nicoletta; Mak, Choi; Mandal, Ranajit; Chowdhury, Rahul Roy; Alamilla-Garcia, Gabriela; Chavez-Blanco, Adriana; Stobart, Hilary; Feeney, Amanda; Vaja, Simran; Hacker, Anne-Marie; Hackshaw, Allan; Ledermann, Jonathan Andrew
errShare
errSave
ICON9: International phase III randomized study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olaparib alone in patients with relapsed platinum-sensitive ovarian cancer following a response to platinum-based chemotherapy
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errNicum, S.; Ledermann, J. A.; Mileshkin, L.; Jayson, G. C.; Gourley, C.; Michael, A.; Lord, R.; Mackay, H.; Hall, M.; Tookman, L.; Banerjee, S.; Harnett, P.; Macdonald, I.; Lee, Y. C.; Elyashiv, O.; Wilkinson, K.; Farrelly, L.; Counsell, N.
errShare
errSave
Induction chemotherapy followed by chemoradiation in locally advanced cervical cancer: Quality of life outcomes of the GCIG INTERLACE trial
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err1
PREAI
errEminowicz, G.; Vaja, S.; Gallardo, D.; Kent, C.; Panades, M.; Anand, A.; Persic, M.; Forrest, J.; Bhana, R.; Adusumalli, M.; Chan, A.; Hacker, A. M.; Hackshaw, A.; Ledermann, J. A.; McCormack, M.
errShare
errSave
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease
errANNALS OF ONCOLOGY
IF65.4
err2024-03-01
err46
errOAAI
errLedermann, J. A.; Matias-Guiu, X.; Amant, F.; Concin, N.; Davidson, B.; Fotopoulou, C.; Gonzalez-Martin, A.; Gourley, C.; Leary, A.; Lorusso, D.; Banerjee, S.; Chiva, L.; Cibula, D.; Colombo, N.; Croce, S.; Eriksson, A. G.; Falandry, C.; Fischerova, D.; Harter, P.; Joly, F.; Lazaro, C.; Lok, C.; Mahner, S.; Marme, F.; Marth, C.; McCluggage, W. G.; Mcneish, I. A.; Morice, P.; Nicum, S.; Oaknin, A.; Perez-Fidalgo, J. A.; Pignata, S.; Ramirez, P. T.; Ray-Coquard, I.; Romero, I.; Scambia, G.; Sehouli, J.; Shapira-Frommer, R.; Sundar, S.; Tan, D. S. P.; Taskiran, C.; van Driel, W. J.; Vergote, I.; Planchamp, F.; Sessa, C.; Fagotti, A.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
D
D. Gareth Evans
H-index: 182 · Papers: 2.5K
D
David G. Huntsman
H-index: 147 · Papers: 1.1K
I
Ignace Vergote
H-index: 135 · Papers: 1.9K
S
Sibylle Loibl
H-index: 131 · Papers: 1.5K
M
Michael J. Birrer
H-index: 126 · Papers: 1.1K
View more